CSL Canada announced today that public access to ANDEMBRY® (garadacimab) is expanding in Canada, with reimbursement now available for eligible patients in Quebec and Alberta, as well as through the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results